Log in
Show password
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 


SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

No Strict Liability For Improper Share Repurchases Or Payment Of Dividends: Directors Are "Fully Protected" If They Rely In Good Faith Upon Corporate Records, Officers, Or Experts

12/01/2021 | 03:09am EST

In re the Chemours Company Derivative Litigation, Vice Chancellor Glasscock recently wrestled with an apparent conflict between two provisions of the Delaware General Corporation Law (DGCL)—and chose the path that protects directors. Vice Chancellor Glasscock refused to hold directors strictly liable for negligent stock repurchases or dividends—which would be inconsistent with Delaware's general limitation on director liability solely to damages for gross negligence (unless exculpated) or loyalty breaches—and instead enforced an “incongruent” provision that accords directors protection where they rely on corporate records, officers, or experts with respect to corporate surplus available to repurchase shares or issue dividends.

Stockholders of Chemours Company alleged that stock repurchases and dividends should not have been paid because Chemours Company faced massive environmental liabilities—not recorded under GAAP—such that it had no corporate surplus and was in fact insolvent or “teetering on insolvency” at the time of the distributions. Even though Plaintiffs themselves had received the dividends, they sought under Section 174 of the DGCL to hold the directors strictly liable to repay to the corporation amounts distributed for stock repurchases and dividends. Plaintiffs alleged that the Director Defendants were at least negligent by relying on GAAP-based accounting (which, they alleged, did not require reserves for the contingent environmental liabilities) to calculate surplus.

Section 174 of the DGCL provides that, where the corporation willfully or negligently repurchases stock or issues dividends where those distributions would exceed corporate surplus, the directors “under whose administration” the violation occurred “shall be jointly and severally liable to the corporation, and to its creditors in the event of its dissolution or insolvency, to the full amount unlawfully paid, with interest.” As Vice Chancellor Glasscock observed, Section 174 “appears to impose strict and several liability on any director vicariously for the negligence of another corporate actor as well as for her own negligence, and impose as damages the full amount paid out even if no actual harm to the corporate interest ultimately manifests itself.”

Section 172, on the other hand, provides that directors are “fully protected” from liability if they rely in good faith upon corporate records, officers, board committees, or other experts “as to the value and amount of the assets, liabilities and/or net profits of the corporation or any other facts pertinent to the existence and amount of surplus or other funds from which dividends might properly be declared and paid, or with which the corporation's stock might properly be purchased or redeemed.” Vice Chancellor Glasscock enforced this provision, finding that Section 174 “must be read in conjunction with” Section 172.

Vice Chancellor Glasscock dismissed the case on demand futility grounds, finding that Plaintiffs had failed to plead specific facts that, if true, imply that the Director Defendants face a substantial likelihood of liability and would be disabled from assessing a demand to bring the claims on behalf of the corporation. In particular, Vice Chancellor Glasscock relied upon the fact that the Board discussed the environmental liabilities on several occasions, and Plaintiffs had not alleged particularized facts undermining the Board's reliance on GAAP-based accounting in connection with its determinations that the stock repurchases and dividend payments complied with the DGCL. The Court also held that Section 172 could be considered at the pleading stage—and that the Board's consultations with management and financial advisors (after receiving presentations about the environmental liabilities) established that they were “fully protected” under Section 172 from personal liability under Section 174.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

Ms Hille R. Sheppard
Sidley Austin LLP
787 Seventh Avenue
New York
New York 10019

© Mondaq Ltd, 2021 - Tel. +44 (0)20 8544 8300 - http://www.mondaq.com, source Business Briefing

01/26RBC Trims Price Target on Chemours to $44 From $45 Amid Expectation of Lower Auto Produ..
01/14Chemours Announces Dates for Fourth Quarter 2021 Earnings Release and Webcast Conferenc..
01/05CHEMOURS : Transcript(opens in new window)
01/04UBS Adjusts Chemours Company Price Target to $36 From $34, Maintains Neutral Rating
2021Chemours Recognized in Newsweek's 2022 List of America's Most Responsible Companies
2021Chemours Signs Non-Binding Deal for Potential Supply of Titanium Feedstocks, Industrial..
2021INSIDER SELL : Chemours
2021Hyperion Metals Signs MoU to Supply Titanium Feedstock from Titan Project in Tennessee
2021Chemours Completes $521 Million Sale of Mining Solutions Business to Czech Cyanide Prod..
2021CHEMOURS : Completes Sale of Mining Solutions Business to Draslovka for $521 Million - For..
More news
Analyst Recommendations on THE CHEMOURS COMPANY
More recommendations
Financials (USD)
Sales 2021 6 336 M - -
Net income 2021 538 M - -
Net Debt 2021 2 447 M - -
P/E ratio 2021 10,2x
Yield 2021 3,04%
Capitalization 5 291 M 5 291 M -
EV / Sales 2021 1,22x
EV / Sales 2022 1,14x
Nbr of Employees 6 500
Free-Float 84,3%
Duration : Period :
The Chemours Company Technical Analysis Chart | CC | US1638511089 | MarketScreener
Technical analysis trends THE CHEMOURS COMPANY
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus OUTPERFORM
Number of Analysts 13
Last Close Price 32,47 $
Average target price 41,75 $
Spread / Average Target 28,6%
EPS Revisions
Managers and Directors
Mark E. Newman President, CEO, COO, Director & Senior VP
Sameer Ralhan Chief Financial Officer & Senior Vice President
Dawn L. Farrell Chairman
Randal King VP-Technology & Advanced Performance Materials
Curtis V. Anastasio Independent Director
Sector and Competitors